Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid ...
21d
Hosted on MSNPurdue Pharma Agrees To $7 Billion Settlement Over OxyContin's Role In Opioid CrisisBankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection ...
NEW YORK — Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread ...
The first full year of the post-COVID-pandemic era was characterized in the United States by continued economic recovery, persistently high consumer interest rates—despite three cuts in the ...
SALT LAKE CITY — Utah is expected to join a settlement with Purdue Pharma, makers of OxyContin, that will resolve thousands of lawsuits alleging that the pain medication caused a widespread ...
Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s ...
Gifting allows recipients to access the article for free. Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results